Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Schrezenmeier

Showing results (1-10 of 288) with videos related to

Pageof 29
Sort By:
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 7, 2024
Classical Haematology: Dynamic Development at the Interface of Transfusion Medicine and HaematologyHubert Schrezenmeier
Expert Review of Hematology|November 19, 2010
Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuriaHubert Schrezenmeier, Britta Höchsmann
Hematology/Oncology Clinics of North America|June 5, 2015
Congenital CD59 DeficiencyBritta Höchsmann, Hubert Schrezenmeier
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 16, 2011
Drugs that inhibit complementHubert Schrezenmeier, Britta Höchsmann
Annals of Hematology|November 9, 2002
Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemiaJudit Demeter, Gerald Messer, Hubert Schrezenmeier
Annals of Hematology|March 2, 2011
Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytesBritta Höchsmann, Markus Rojewski, Hubert Schrezenmeier
Deutsche Medizinische Wochenschrift (1946)|June 7, 2022
[Rational therapy with erythrocyte concentrates - Update 2022]Bernd Schoenes, Hubert Schrezenmeier, Martin Welte
Expert Review of Hematology|January 10, 2015
Immunosuppressive therapy for transplant-ineligible aplastic anemia patientsHubert Schrezenmeier, Sixten Körper, Britta Höchsmann
Deutsche Medizinische Wochenschrift (1946)|March 20, 2023
[Value of convalescent plasma in the therapy of COVID-19]Sixten Körper, Erhard Seifried, Hubert Schrezenmeier
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Immunotherapy for cancer: promoting innate immunityRamin Lotfi, Hubert Schrezenmeier, Michael Thomas Lotze
Pageof 29

Showing results (1-10 of 288) with videos related to

Sort By:
Pageof 29
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 7, 2024
Classical Haematology: Dynamic Development at the Interface of Transfusion Medicine and HaematologyHubert Schrezenmeier
Expert Review of Hematology|November 19, 2010
Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuriaHubert Schrezenmeier, Britta Höchsmann
Hematology/Oncology Clinics of North America|June 5, 2015
Congenital CD59 DeficiencyBritta Höchsmann, Hubert Schrezenmeier
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 16, 2011
Drugs that inhibit complementHubert Schrezenmeier, Britta Höchsmann
Annals of Hematology|November 9, 2002
Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemiaJudit Demeter, Gerald Messer, Hubert Schrezenmeier
Annals of Hematology|March 2, 2011
Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytesBritta Höchsmann, Markus Rojewski, Hubert Schrezenmeier
Deutsche Medizinische Wochenschrift (1946)|June 7, 2022
[Rational therapy with erythrocyte concentrates - Update 2022]Bernd Schoenes, Hubert Schrezenmeier, Martin Welte
Expert Review of Hematology|January 10, 2015
Immunosuppressive therapy for transplant-ineligible aplastic anemia patientsHubert Schrezenmeier, Sixten Körper, Britta Höchsmann
Deutsche Medizinische Wochenschrift (1946)|March 20, 2023
[Value of convalescent plasma in the therapy of COVID-19]Sixten Körper, Erhard Seifried, Hubert Schrezenmeier
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Immunotherapy for cancer: promoting innate immunityRamin Lotfi, Hubert Schrezenmeier, Michael Thomas Lotze
Pageof 29